Founded
Address
Domain Associates LLC
12481 High Bluff Drive
Suite 150
San Diego, CA 92130
United States
Phone
Email
Website
Recent investment activity
KANDO id: 31340
Company type
Venture capital firm focused on life sciences companies.Funding rounds
Investment preferences
Investment activity status
Active investor
Selected investments
Displaying 26 - 50 of 143| Company | Profile | Country | Date Sort ascending | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Celator Pharmaceuticals | Identifies ratios of synergistic drug combinations in vitro, and fixes ratios in liposomal drug carriers for in vivo treatment of various cancers. | Series C | |||
|
Zogenix Inc | A pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain. | N/A Initial investment | |||
|
|
CoLucid Pharmaceuticals | Biopharmaceutical company developing therapeutics to treat neurological dysfunctions. | Series B | |||
|
|
Tobira Therapeutics Inc | Dedicated to the clinical development of antiviral products | Series A | |||
|
|
GenVault Corp | Venture | ||||
|
|
BiPar Sciences Inc | Biopharmaceutical company developing and commercializing tumor-selective drugs for cancer patients. | Series B | |||
|
|
CoLucid Pharmaceuticals | Biopharmaceutical company developing therapeutics to treat neurological dysfunctions. | Series A | |||
|
|
ProteinSimple | ProteinSimple's goal is simply to help researchers gain a better understanding of proteins and their role in disease. | Series B | |||
|
|
Alimera Sciences Inc | Biopharmaceutical company. | Series B Initial investment | |||
|
|
DiObex Inc | Biotechnology company that develops novel products for the treatment of metabolic disorders. | N/A | |||
|
|
Celator Pharmaceuticals | Identifies ratios of synergistic drug combinations in vitro, and fixes ratios in liposomal drug carriers for in vivo treatment of various cancers. | N/A | |||
|
|
Iomai Corp | Biopharmaceutical company focused on discovering and developing vaccines and immune system stimulants. | Series C | |||
|
|
Symphony Medical Inc | Series A | ||||
|
|
Connetics Corp | N/A | ||||
|
|
BioSphere Medical Inc | Medical device company that develops, manufactures, and markets products for medical procedures that use embolotherapy. | N/A | |||
|
|
Inhibitex Inc | N/A | ||||
|
|
Aurora Biosciences Corp | N/A | ||||
|
|
Auxeris Therapeutics Inc | Osteoporosis drug development | N/A | |||
|
|
Martek Biosciences Corp | N/A | ||||
|
|
Biomagnetic Technologies Inc | Instrumentation for ultra-sensitive magnetic measurement | N/A | |||
|
|
Sunesis Pharmaceuticals Inc | Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and he | N/A | |||
|
|
Biosite Diagnostics Inc | Discovery, development and marketing of rapid diagnostics | N/A | |||
|
|
IntraLase Corp | N/A | ||||
|
|
BioVascular Inc | N/A | ||||
|
|
Cabrellis Pharmaceuticals Corp | Development of important therapies for the treatment of cancer | N/A |